| | |||||||
| technology | |||||||
| NEWS | |||||||
'Some may die': AGA urges continued access to conventional FMT for C. difficile patients As of Nov. 1, OpenBiome suspended its distribution of investigational fecal microbiota transplantation, which may put certain patients with recurrent, refractory or fulminant Clostridioides difficile infection at risk, according to the AGA.
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment